Pretoria – In recent days, the study by the Institute of Health study conducted in South Africa confirming the effectiveness of a new vaccine was published in the journal Retrovirology. The phase II of the clinical study conducted in South Africa confirmed that the Tat vaccine against HIV / AIDS can improve the treatment of HIV infection. The results were published in Retrovirology, one of the most influential newspapers in the field of HIV / AIDS. The vaccine was developed in the laboratories of the Institute of Health by the Italian National AIDS Center (CNAIDS), directed by Dr. Barbara Ensoli. (9Colonne)
